Virax Biolabs Group Limited

Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, announced today that it has entered into definitive agreements for the purchase and sale of 3,843,309 ordinary shares (or ordina

Gainers Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) rose 51.1% to $2.66 in pre-market trading after the company disclosed topline results from single and multiple ascending dose parts of Phase 1 study of oral DYRK1A inhibitor FRTX-02.

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 450 points on Tuesday. The Dow traded down 1.68% to 32,868.40 while the NASDAQ fell 1.31% to 11,523.25. The S&P 500 also fell, dropping, 1.55% to 3,985.47.

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the European market.

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Tuesday. The Dow traded down 0.77% to 33,172.39 while the NASDAQ fell 0.72% to 11,591.36. The S&P 500 also fell, dropping, 0.91% to 4,011.71.

Virax Biolabs Group Ltd (NASDAQ: VRAX) shares are trading higher on abnormally high volume Tuesday after the company announced an agreement for the distribution of an Avian Influenza A Virus (AIV)

FedEx (FDX) - Will report quarterly results on Thursday, March 16 after market close. Analysts at Morgan Stanley issued a note Tuesday morning noting their expectation for FedEx's Q3 results to